Low-dose ATG is effective in treatment of acute rejection episodes.
Sharma
R K
RK
Department of Nephrology & Urology Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Kumar
A
A
Kumar
J
J
Gupta
A
A
Gulati
S
S
Sharma
A P
AP
Bhandari
M
M
Kumar
A
A
D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D013997:Time Factors; D016896:Treatment Outcome
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents